VVOS logo

Vivos Therapeutics (VVOS) Revenue

Annual Revenue

$13.80 M
-$2.22 M-13.87%

December 31, 2023


Summary


Performance

VVOS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVVOSprofitabilitymetrics:

Quarterly Revenue

$3.86 M
-$194.00 K-4.79%

September 30, 2024


Summary


Performance

VVOS Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$14.58 M
+$559.00 K+3.99%

September 30, 2024


Summary


Performance

VVOS TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVVOSprofitabilitymetrics:

VVOS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.9%0.0%0.0%
3 y3 years+5.6%-15.1%-7.7%
5 y5 years+263.9%+11.9%+9.5%

VVOS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.3%at low-12.2%+18.8%-14.6%+9.1%
5 y5-year-18.3%+21.1%-15.1%+26.3%-14.6%+128.8%
alltimeall time-18.3%+263.9%-15.1%+26.3%-14.6%+339.7%

Vivos Therapeutics Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.86 M(-4.8%)
$14.58 M(+4.0%)
Jun 2024
-
$4.05 M(+18.6%)
$14.02 M(+4.9%)
Mar 2024
-
$3.42 M(+5.3%)
$13.36 M(-3.2%)
Dec 2023
$13.80 M(-13.9%)
$3.25 M(-1.6%)
$13.80 M(-4.8%)
Sep 2023
-
$3.30 M(-2.8%)
$14.50 M(-6.1%)
Jun 2023
-
$3.40 M(-12.0%)
$15.45 M(-4.9%)
Mar 2023
-
$3.86 M(-2.4%)
$16.24 M(+1.3%)
Dec 2022
$16.02 M(-5.1%)
$3.95 M(-7.0%)
$16.02 M(-2.7%)
Sep 2022
-
$4.25 M(+1.5%)
$16.47 M(-1.8%)
Jun 2022
-
$4.18 M(+14.8%)
$16.77 M(-1.8%)
Mar 2022
-
$3.64 M(-17.1%)
$17.08 M(+1.2%)
DateAnnualQuarterlyTTM
Dec 2021
$16.89 M(+29.2%)
$4.39 M(-3.3%)
$16.89 M(+6.9%)
Sep 2021
-
$4.55 M(+1.1%)
$15.80 M(+8.6%)
Jun 2021
-
$4.50 M(+30.4%)
$14.54 M(+9.2%)
Mar 2021
-
$3.45 M(+4.3%)
$13.32 M(+1.9%)
Dec 2020
$13.07 M(+14.7%)
$3.31 M(+0.5%)
$13.07 M(+2.0%)
Sep 2020
-
$3.29 M(+0.6%)
$12.81 M(-0.2%)
Jun 2020
-
$3.27 M(+2.3%)
$12.84 M(+34.2%)
Mar 2020
-
$3.20 M(+4.6%)
$9.57 M(+50.2%)
Dec 2019
$11.39 M(+200.4%)
$3.06 M(-7.8%)
$6.37 M(+92.2%)
Sep 2019
-
$3.32 M
$3.32 M
Dec 2018
$3.79 M
-
-

FAQ

  • What is Vivos Therapeutics annual revenue?
  • What is the all time high annual revenue for Vivos Therapeutics?
  • What is Vivos Therapeutics annual revenue year-on-year change?
  • What is Vivos Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Vivos Therapeutics?
  • What is Vivos Therapeutics quarterly revenue year-on-year change?
  • What is Vivos Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Vivos Therapeutics?
  • What is Vivos Therapeutics TTM revenue year-on-year change?

What is Vivos Therapeutics annual revenue?

The current annual revenue of VVOS is $13.80 M

What is the all time high annual revenue for Vivos Therapeutics?

Vivos Therapeutics all-time high annual revenue is $16.89 M

What is Vivos Therapeutics annual revenue year-on-year change?

Over the past year, VVOS annual revenue has changed by -$2.22 M (-13.87%)

What is Vivos Therapeutics quarterly revenue?

The current quarterly revenue of VVOS is $3.86 M

What is the all time high quarterly revenue for Vivos Therapeutics?

Vivos Therapeutics all-time high quarterly revenue is $4.55 M

What is Vivos Therapeutics quarterly revenue year-on-year change?

Over the past year, VVOS quarterly revenue has changed by $0.00 (0.00%)

What is Vivos Therapeutics TTM revenue?

The current TTM revenue of VVOS is $14.58 M

What is the all time high TTM revenue for Vivos Therapeutics?

Vivos Therapeutics all-time high TTM revenue is $17.08 M

What is Vivos Therapeutics TTM revenue year-on-year change?

Over the past year, VVOS TTM revenue has changed by $0.00 (0.00%)